A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality.
Level 3 - non-randomized controlled study
Prospective longitudinal follow-up study with a non-randomized control group
PubMed 25124710 · doi:10.1016/j.bbi.2014.07.012
What was done
Researchers examined the longitudinal relationship between neuroinflammation, kynurenine pathway metabolites in cerebrospinal fluid (CSF), and symptoms of depression and suicidality. CSF cytokines and kynurenine metabolites (specifically quinolinic acid and kynurenic acid) were repeatedly sampled over a 2-year period in 30 suicide attempters (total of 143 patient samples) and compared to 36 healthy controls. Psychiatric symptom severity was evaluated across time using the Montgomery–Åsberg Depression Rating Scale (MADRS) and the Suicide Assessment Scale (SUAS).
What was found
The abstract reports directional findings without numerical values (no means, effect sizes, or p-values are reported). Over 2 years, suicidal patients had increased quinolinic acid and decreased kynurenic acid in CSF compared to healthy controls. Within patients, low kynurenic acid was significantly associated with more severe depressive symptoms, and high interleukin-6 (IL-6) levels were significantly associated with more severe suicidal symptoms.
Why it matters
The study provides longitudinal human CSF evidence that central kynurenine pathway dysregulation and low-grade neuroinflammation track with symptom severity in suicidal depression, supporting the hypothesis that NMDA receptor modulation via neurotoxic metabolites plays a functional role in suicidal behavior.
Limits
The patient sample size is small (30 individuals), limiting generalizability and subgroup comparisons. The abstract provides no numerical data, confidence intervals, or exact p-values. As an observational study, it cannot establish whether kynurenine pathway shifts cause symptom exacerbations or arise secondary to psychiatric distress, medication use, or lifestyle factors.
Cited by
- supports A study found that suicide attempters had up to 300% elevated levels of quinolinic acid in their cerebrospinal fluid.